Key Account Manager
Ultragenyx Pharmaceutical
Key Account Manager
Ultragenyx Pharmaceutical
Develops and commercializes rare-disease therapies
ultracurious – Apply your biggest ideas in courageous ways
The Key Account Manager is responsible for the successful commercialization of Ultragenyx products in the assigned territory. In this function, he/she will be accountable for attaining revenue and profitability goals and independently analyze the decision-making and patient referral patterns in the territory. He/she will drive initiatives to impove patient care by educating stakeholders.
We are looking for open-minded personalities with a pioneering spirit who are eager to explore new opportunites, unafraid of venturing into uncharted territory, who have the ambition and self-motivation to develop innovative strategies with the intention to improve patient care. We welcome entrepreneurial thinking, strong commitment to business integrity and, above all, commitment to true patient-centricity.
Field: Officially documented as working as a member of the Ultragenyx field team, generally interacting with third parties on behalf of Ultragenyx.
#LI-CK1 #LI-Remote
Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at [email protected].
Develops and commercializes rare-disease therapies
Ultragenyx develops and commercializes therapies for rare and ultra-rare genetic diseases. Its products move from clinical development to FDA approval and market, including burosumab for Tumor Induced Osteomalacia and UX007 for Long-chain Fatty Acid Oxidation Disorders. The company differentiates itself with a diversified pipeline and a strong commitment to uninterrupted patient access, serving a niche, high-need market. Its goal is to translate scientific research into effective, accessible treatments and establish leadership in the rare-disease treatment market.
Explore more opportunities at Ultragenyx Pharmaceutical